CODX Earnings

CODX reported its FY2025Q3 earnings on 2025-11-13, showcasing a revenue of 145.38K against an estimate of 300.00K, resulting in a -51.54% surprise. The EPS was -0.16, surpassing the expected -0.19 by 15.79%. The stock experienced a -10.94% price change on the earnings day and a -7.98% change over the next five days, reflecting market reactions to the results.

Following CODX's FY2025Q3 earnings announcement on 2025-11-13, the stock price moved by -10.94% on the day of the release. Over the subsequent five days, it saw a -7.98% change. Historically, CODX's stock price tends to shift by an average of 4.44% in the 10 days leading up to earnings and -0.96% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate CODX's annual revenue to reach 163.50K, while the EPS is projected at -3.75. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CODX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CODX's stock price typically moves by 4.44% in the 10 days before its earnings and -0.96% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -3.75 and revenue of 163.50K.

The earnings call revealed significant challenges, including regulatory hurdles, decreased revenue, and increased expenses. The company's Co-Dx PCR platform, a key strategic initiative, faces regulatory and commercial adoption risks. Additionally, the financial performance showed declines in revenue, net income, and gross margin, with increased operating expenses. The lack of a shareholder return plan and unclear management responses further contribute to a negative outlook. Given these factors, the stock price is likely to experience a strong negative reaction.